Use of health-related quality of life in prescribing research. Part 2: Methodological considerations for the assessment of health-related quality of life in clinical trials

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 1, 2004, Pages 85-94

  Calvert, M J ^a   Freemantle, N ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Health related quality of life; Missing data; Protocol; Randomized controlled trial; Timing

Indexed keywords

ACCURACY; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; DECISION MAKING; ETHNIC GROUP; EVALUATION; FOLLOW UP; HUMAN; LANGUAGE; METHODOLOGY; PATIENT COMPLIANCE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; TREATMENT OUTCOME;

CLINICAL TRIALS; DATA COLLECTION; HEALTH STATUS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY OF LIFE; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 1342331445     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0269-4727.2003.00520.x     Document Type: Article

References (42)

1. Calvert MJ, Freemantle N (2004) Research Note: use of health-related quality of life in prescribing research, Part 1. Journal of Clinical Pharmacy and Therapeutics (In Press).
2. Sanders C, Egger M, Donovan J, Tallon D, Frankel S (1998) Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ, 317, 1191-1194.
3. Efficace F, Bottomley A (2002) Do quality-of-life randomized clinical trials support clinicians in their decision-making? Journal of Clinical Oncology, 20, 4126-4127.
4. Lee CW, Chi KN (2000) The standard of reporting of health-related quality of life in clinical cancer trials. Journal of Clinical Epidemiology, 53, 451-458.
5. http://www.eortc.be/home/qol/ (accessed 26/09/2003).
6. Bottomley A, Vanvoorden V, Flechtner H, Therasse P, on behalf of the EORTC Quality of Life Group and the EORTC Data Centre (2003) The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials. European Journal of Cancer, 39, 275-285.
7. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R on behalf of the MRC Cancer Trials Office (1997) Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers: the U.K. medical research council experience. European Journal of Cancer, 33, 20-28.
8. Neymark N, Kiebert W, Torfs K et al. (1998) Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop. European Journal of Cancer, 34, 1317-1333.
9. ICH Harmonised Tripartite Guideline (1999) Statistical Principles for Clinical Trials (ICH E9). Statistics in Medicine, 18, 1905-1942.
10. http://www.ich.org/ (accessed 26/09/2003).
11. Freemantle N, Eastaugh J (2002) Using effectiveness studies for prescribing research, part 1. Journal of Clinical Pharmacy and Therapeutics, 27, 383-389.
12. Freemantle N, Eastaugh J (2002) Using effectiveness studies for prescribing research, part 2. Journal of Clinical Pharmacy and Therapeutics, 27, 469-473.
13. Kiebert GM, Curran D, Aaronson NK (1998) Quality of Life as and Endpoint in EORTC Clinical Trials. Statistics in Medicine, 17, 561-569.
14. Kaasa S, Loge JH (2002) Quality-of-life assessment in palliative care. The Lancet Oncology, 3, 175-182.
15. Abraham WT, Fisher WG, Smith AL et al. (2002) Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346, 1845-1853.
16. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N for the European Regulatory Issues on Quality of Life assessment Group (2002) Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209-238.
17. Fayers PM, Machin D (2000) Quality of life assessment, analysis and interpretation. Chichester: Wiley.
18. Freemantle N (2001) Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ, 322, 989-991.
19. Cazeau S, Leclercq C, Lavergne T et al. (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New England Journal of Medicine, 344, 873-880.
20. Cleland JGF, Daubert JC, Erdmann E et al. and on behalf of the CARE-HF Study Steering Committee and Investigators (2001) The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. European Journal of Heart Failure, 3, 481-489.
21. Gelber RD, Gelber S (1995) Quality-of-life assessment in clinical trials. Cancer Treatment and Research, 75, 225-246.
22. Aaronson NK, Ahmedzai S, Bergman B et al. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.
23. Bernhard J, Cella DF, Coates AS et al. (1998) Missing quality of life data in cancer clinical trials: serious problems and challenges. Statistics in Medicine, 17, 517-532.
24. Fairclough, DL (2002) Design and analysis of quality of life studies in clinical trials. Boca Raton: Chapman & Hall/CRC.
25. Bullinger M, Alonso J, Apolone G et al. (1998) Translating health status questionnaires and evaluating their quality: the IQOLA project approach. Journal of Clinical Epidemiology, 51, 913-923.
26. Mkoka S, Vaughan J, Wylie T, Yelland H, Jelsma J (2003) The pitfalls of translation - a case study based on the translation of the EQ-5D into Xhosa. South African Medical Journal, 93, 265-266.
27. Eisen GM, Locke GR, Provenzale D (1999) Health-related quality of life: a primer for gastroenterologists. The American Journal of Gastroenterology, 94, 2017-2021.
28. Fitzpatrick R, Davey C, Buxton M, Jones D (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2, 1-74.
29. http://www.sf-36.org (accessed 26/09/2003).
30. Kind P. (2001) The measurement of quality of life in clinical trials: considerations of good research practice. Report of the ISPOR Health Science Committee. http://www.ispor.org/workpaper/healthscience/TFQoL.pdf (accessed 15/10/2003).
31. Brooks MM, Jenkins LS, Schron EB, Steinberg JS, Cross JA, Paeth DS for the AVID Investigators (1998) Quality of life at baseline: is assessment after randomization valid? Medical Care, 36, 1515-1519.
32. Simes RJ, Greatorex V, Gebski VJ (1998) Practical approaches to minimize problems with missing quality of life data. Statistics in Medicine, 17, 725-737.
33. Billingham LJ (2003) Statistical methods for the simultaneous analysis of quality of life and survival data, PhD Thesis, University of Leicester.
34. Cullen M, Billingham L, Woodroffe C et al. (1999) Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. Journal of Clinical Oncology, 17, 3188-3194.
35. Machin D, Weeden S (1998) Suggestions for the presentation of quality of life data from clinical trials. Statistics in Medicine, 17, 711-724.
36. Fayers PM, Curran D, Machin D (1998) Incomplete quality of life data in randomized trials: missing items. Statistics in Medicine, 17, 679-696.
37. Fairclough DL, Peterson HF, Chang V (1998) Why are missing quality of life data a problem in clinical trials of cancer therapy? Statistics in Medicine, 17, 667-677.
38. Addington-Hall J, Kalra L (2001) Measuring quality of life: who should measure quality of life? BMJ, 322, 1417-1420.
39. Euroqol Group (2001) EQ-5D a measure of health-related quality of life developed by the Euroqol group, User Guide, http://www.euroqol.org (accessed 26/09/2003).
40. Curran D, Molenberghs G, Fayers PM, Machin D (1998) Incomplete quality of life data in randomized trials: missing forms. Statistics in Medicine, 17, 697-709.
41. Moher D, Schulz KF, Altman D, for the CONSORT Group (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA, 285, 1987-1991.
42. Staquet M, Berzon R, Osoba D, Machin D (1996) Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research, 5, 496-502.